This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, C.-Y.
Right arrow Articles by Cheng, A. F. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, C.-Y.
Right arrow Articles by Cheng, A. F. B.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2004, p. 340-343, Vol. 48, No. 1
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.1.340-343.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

In Vitro Postantibiotic Effects of Rifapentine, Isoniazid, and Moxifloxacin against Mycobacterium tuberculosis

Chiu-Yeung Chan,1* Carrie Au-Yeang,1 Wing-Wai Yew,2 Chi-Chiu Leung,3 and Augustine F. B. Cheng1

Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories,1 Tuberculosis and Chest Unit, Grantham Hospital, Aberdeen,2 Tuberculosis and Chest Service, Department of Health, Hong Kong3

Received 6 August 2003/ Returned for modification 18 August 2003/ Accepted 6 October 2003

Postantibiotic effects (PAEs) of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis ATCC 27294 were studied using a radiometric culture system. Rifapentine at 20 mg/liter gave the longest PAE (104 h) among the drugs used alone. The combinations of rifapentine plus isoniazid, rifapentine plus moxifloxacin, and isoniazid plus moxifloxacin gave PAEs of 136.5, 59.0, and 8.3 h, respectively.

* Corresponding author. Mailing address: Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong. Phone: (852) 2632-2875. Fax: (852) 2647-3227. E-mail: chiuychan{at}cuhk.edu.hk.

Antimicrobial Agents and Chemotherapy, January 2004, p. 340-343, Vol. 48, No. 1
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.1.340-343.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • van den Boogaard, J., Kibiki, G. S., Kisanga, E. R., Boeree, M. J., Aarnoutse, R. E. (2009). New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development. Antimicrob. Agents Chemother. 53: 849-862 [Full Text]  
  • Reddy, V. M., Einck, L., Nacy, C. A. (2008). In Vitro Antimycobacterial Activities of Capuramycin Analogues. Antimicrob. Agents Chemother. 52: 719-721 [Abstract] [Full Text]  
  • Shandil, R. K., Jayaram, R., Kaur, P., Gaonkar, S., Suresh, B. L., Mahesh, B. N., Jayashree, R., Nandi, V., Bharath, S., Balasubramanian, V. (2007). Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis: Evaluation of In Vitro and Pharmacodynamic Indices That Best Predict In Vivo Efficacy. Antimicrob. Agents Chemother. 51: 576-582 [Abstract] [Full Text]  
  • Sirgel, F. A., Fourie, P. B., Donald, P. R., Padayatchi, N., Rustomjee, R., Levin, J., Roscigno, G., Norman, J., McIlleron, H., Mitchison, D. A., the Rifapentine EBA Collaborative Study Group, (2005). The Early Bactericidal Activities of Rifampin and Rifapentine in Pulmonary Tuberculosis. Am. J. Respir. Crit. Care Med. 172: 128-135 [Abstract] [Full Text]  
  • Ginsburg, A. S., Lee, J., Woolwine, S. C., Grosset, J. H., Hamzeh, F. M., Bishai, W. R. (2005). Modeling In Vivo Pharmacokinetics and Pharmacodynamics of Moxifloxacin Therapy for Mycobacterium tuberculosis Infection by Using a Novel Cartridge System. Antimicrob. Agents Chemother. 49: 853-856 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»